PostYou are now at: Home » Products » Chemicals » Other Chemicals »

High Quality with purity 4-Hydroxy Testosterone ; CAS:566-48-3

Click image to view original image
规格: White crystalline odourless solid
Price: Negotiable
Min.Order: 10 10
Supply 2 10
Delivery: Shipment within 3 days since the date of payment
Address: China
Valid until: 2028-05-15
Updated on: 2016-02-18 11:32
Hits: 2541729
Enquiry
Company Detail
 
 
Details

4-Hydroxy Testosterone
Chemical Name: 4-Androsten-4,17beta-ol-3-one
CAS:566-48-3
Molecular Formula: C19H28O3
Molecular weight: 304.42
Standard: Enterprise Standard

Basic Info.
Model NO.:566-48-3Name:FormestaneAlias:Lentaron566-48-3:Cancer Treatment SteroidsFormula:C19h26o3Assay:99%MW:302.41Appearance:White PowderGrade:Pharmaceutical GradeType:Raw Steroid PowderExport Markets:Global
Additional Info.
Trademark:simeiquanPacking:Amazing Discreet PackingStandard:USP/BP/GMPOrigin:ChinaProduction Capacity:5000kg/Month
Product Description
Anti Estrogen and PCT Steroids Formestane 566-48-3 Aromatizing For Breast Cancer

What is the Formestane ?
Formestane is currently one of the best legal anti-estrogens out there.It is classified as an irreversible arromatase inhibitor, meaning, it destroys the aromatase enzyme.

Formestane is a synthetic steroidal substance with antineoplastic activity.Formestane binds irreversibly to and inhibits the enzyme aromatase, thereby blocking the conversion of cholesterol to pregnenolone and the peripheral aromatization of androgenic precursors into estrogens.

Formestane is a drug that has been previously used in breast cancer treatment.Like most drugs which have some sort of phsyique usage, athletes eventually get a hold of it.Formestane is currently one of the best legal anti-estrogens out there.It is classified as an irreversible arromatase inhibitor, meaning, it destroys the aromatase enzyme.

Quick detail :

 

Total: 0 [Show All]  Related Reviews
 
More »Our Others Products

[ ProductsSearch ]  [ Add To Favourite ]  [ Tell Friends ]  [ Print Content ]  [ Violation Report ]  [ Close Window ]